Medison Pharma Announces the Approvals by Health Canada and Therapeutics Goods Administration of KIMMTRAK® (tebentafusp) for the Treatment of Unresectable or Metastatic Uveal Melanoma
Petach Tikvah, Israel (ots/PRNewswire) - KIMMTRAK has been approved in Canada and Australia for the treatment of an aggressive form of ocular melanoma and follows approval in the United States and the European Union Today, Medison Pharma ("Medison"), a global pharma company focused on providing access to highly ...